Anne Gardiner

5.7k total citations · 1 hit paper
27 papers, 3.4k citations indexed

About

Anne Gardiner is a scholar working on Genetics, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Anne Gardiner has authored 27 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 17 papers in Pathology and Forensic Medicine and 10 papers in Molecular Biology. Recurrent topics in Anne Gardiner's work include Chronic Lymphocytic Leukemia Research (24 papers), Lymphoma Diagnosis and Treatment (17 papers) and Glycosylation and Glycoproteins Research (10 papers). Anne Gardiner is often cited by papers focused on Chronic Lymphocytic Leukemia Research (24 papers), Lymphoma Diagnosis and Treatment (17 papers) and Glycosylation and Glycoproteins Research (10 papers). Anne Gardiner collaborates with scholars based in United Kingdom, Germany and United States. Anne Gardiner's co-authors include David Oscier, Zadie Davis, Terry J. Hamblin, Freda K. Stevenson, Sarah Mould, J. A. Copplestone, Martin Corcoran, Rachel Ibbotson, Sharron Glide and Robert M. Chapman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Anne Gardiner

27 papers receiving 3.3k citations

Hit Papers

Unmutated Ig VH Genes Are Associated With a More Aggressi... 1999 2026 2008 2017 1999 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Gardiner United Kingdom 15 3.1k 2.2k 1.6k 801 455 27 3.4k
Alexander Kröber Germany 20 3.9k 1.3× 2.9k 1.3× 2.0k 1.2× 852 1.1× 683 1.5× 28 4.4k
Elke Leupolt Germany 11 2.5k 0.8× 1.9k 0.9× 1.2k 0.7× 666 0.8× 573 1.3× 11 2.9k
Andreas Bühler Germany 21 2.2k 0.7× 1.6k 0.7× 920 0.6× 599 0.7× 520 1.1× 47 2.7k
Jenny Orchard United Kingdom 11 1.6k 0.5× 1.3k 0.6× 808 0.5× 289 0.4× 304 0.7× 18 1.7k
Zachary R. Hunter United States 41 5.1k 1.7× 4.3k 2.0× 2.5k 1.5× 901 1.1× 902 2.0× 231 6.2k
Lilla Cro Italy 19 1.0k 0.3× 722 0.3× 544 0.3× 820 1.0× 472 1.0× 30 1.9k
H. Döhner Germany 19 1.1k 0.4× 850 0.4× 507 0.3× 546 0.7× 441 1.0× 27 1.8k
Stefan Gesk Germany 37 1.2k 0.4× 2.5k 1.1× 886 0.5× 1.5k 1.8× 1.4k 3.0× 80 4.3k
Mats Merup Sweden 24 1.1k 0.4× 969 0.4× 658 0.4× 739 0.9× 632 1.4× 59 2.2k
Monica Messina Italy 20 845 0.3× 1.1k 0.5× 455 0.3× 803 1.0× 581 1.3× 49 2.2k

Countries citing papers authored by Anne Gardiner

Since Specialization
Citations

This map shows the geographic impact of Anne Gardiner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Gardiner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Gardiner more than expected).

Fields of papers citing papers by Anne Gardiner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Gardiner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Gardiner. The network helps show where Anne Gardiner may publish in the future.

Co-authorship network of co-authors of Anne Gardiner

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Gardiner. A scholar is included among the top collaborators of Anne Gardiner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Gardiner. Anne Gardiner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davis, Zadie, Francesco Forconi, Anton Parker, et al.. (2016). The outcome of Chronic lymphocytic leukaemia patients with 97% IGHV gene identity to germline is distinct from cases with <97% identity and similar to those with 98% identity. British Journal of Haematology. 173(1). 127–136. 15 indexed citations
2.
Parry, Marina, Matthew Rose‐Zerilli, Jane Whitney Gibson, et al.. (2013). Whole Exome Sequencing Identifies Novel Recurrently Mutated Genes in Patients with Splenic Marginal Zone Lymphoma. PLoS ONE. 8(12). e83244–e83244. 51 indexed citations
3.
Rouhi, Leila, José Luis Ferreiro, Lucienne Michaux, et al.. (2013). BMI1, The polycomb‐group gene, is recurrently targeted by genomic rearrangements in progressive B‐cell leukemia/lymphoma. Genes Chromosomes and Cancer. 52(10). 928–944. 19 indexed citations
4.
Oscier, David, Matthew Rose‐Zerilli, Nils Winkelmann, et al.. (2012). The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial. Blood. 121(3). 468–475. 150 indexed citations
5.
Rose‐Zerilli, Matthew, Jade Forster, Helen Parker, et al.. (2012). The Correlation Between Deletion Architecture, ATM Mutational Status and BIRC3 Disruption in 11q-Deleted CLL. Blood. 120(21). 658–658. 2 indexed citations
7.
Pepper, Chris, Aneela Majid, Thet Thet Lin, et al.. (2011). Defining the prognosis of early stage chronic lymphocytic leukaemia patients. British Journal of Haematology. 156(4). 499–507. 33 indexed citations
8.
Pratt, Guy, Philip J. Young, Chris Pepper, et al.. (2011). 4.1 Elevated Serum Free Light Chains Independently Identify a Poor Risk Group of Stage A CLL Patients. Clinical Lymphoma Myeloma & Leukemia. 11. S218–S218. 1 indexed citations
9.
Strefford, Jonathan C., Helen Parker, Anton Parker, et al.. (2009). 13q Deletion Size Predicts Disease Progression and Response to Treatment in Patients with Chronic Lymphocytic Leukaemia.. Blood. 114(22). 671–671. 3 indexed citations
10.
Pratt, Guy, Stephen Harding, Chris Fegan, et al.. (2009). Serum FLC Levels at Presentation Have Independent Prognostic Significance in CLL and Levels Above 50mg/L Identify Patients with Progressive Disease.. Blood. 114(22). 2355–2355. 2 indexed citations
11.
Pratt, Guy, Stephen Harding, Roger Holder, et al.. (2008). Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia. British Journal of Haematology. 144(2). 217–222. 38 indexed citations
12.
Austen, Belinda, Anna Skowrońska, Judith E. Powell, et al.. (2007). Mutation Status of the Residual ATM Allele Is an Important Determinant of the Cellular Response to Chemotherapy and Survival in Patients With Chronic Lymphocytic Leukemia Containing an 11q Deletion. Journal of Clinical Oncology. 25(34). 5448–5457. 167 indexed citations
13.
Oscier, David, Anne Gardiner, Sarah Mould, et al.. (2004). The Natural History of Mutated, Stage AO Chronic Lymphocytic Leukemia.. Blood. 104(11). 954–954. 1 indexed citations
14.
Ibbotson, Rachel, Jennifer Orchard, Anne Gardiner, et al.. (2003). P2X7 polymorphism and chronic lymphocytic leukaemia: lack of correlation with incidence, survival and abnormalities of chromosome 12. Leukemia. 17(11). 2097–2100. 42 indexed citations
15.
16.
Oscier, David & Anne Gardiner. (2001). Lymphoid neoplasms. Best Practice & Research Clinical Haematology. 14(3). 609–630. 4 indexed citations
17.
Hamblin, Terry J., Zadie Davis, Anne Gardiner, David Oscier, & Freda K. Stevenson. (1999). Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia. Blood. 94(6). 1848–1854. 1961 indexed citations breakdown →
18.
Hamblin, Terry J., Zadie Davis, Anne Gardiner, David Oscier, & Freda K. Stevenson. (1999). Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia. Blood. 94(6). 1848–1854. 139 indexed citations
19.
Corcoran, Martin, Omid Rasool, Yie Liu, et al.. (1998). Detailed Molecular Delineation of 13q14.3 Loss in B-Cell Chronic Lymphocytic Leukemia. Blood. 91(4). 1382–1390. 80 indexed citations
20.
Gardiner, Anne, Martin Corcoran, & David Oscier. (1997). Cytogenetic, fluorescence in situ hybridisation, and clinical evaluation of translocations with concomitant deletion at 13q14 in chronic lymphocytic leukaemia. Genes Chromosomes and Cancer. 20(1). 73–81. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026